Citigroup Inc Intellia Therapeutics, Inc. Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
A detailed history of Citigroup Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Citigroup Inc holds 276,930 shares of NTLA stock, worth $2.66 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
276,930
Previous 167,560
65.27%
Holding current value
$2.66 Million
Previous $3.44 Million
6.22%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $731M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...